Factors influencing early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirin

Hepatology Research

Volumn 32, Issue 4, 2005, Pages 224-226

  Kowala Piaskowska, Arleta ^a   Słuzewski, Wojciech ^a   Figlerowicz, Magdalena ^a   Mozer Lisewska, Iwona ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Chronic hepatitis C; Combined therapy in children with CHC; Pegylated interferon

Indexed keywords

ALANINE AMINOTRANSFERASE; PEGINTERFERON ALPHA2B; RIBAVIRIN;

AGGRESSION; APPETITE DISORDER; ARTHRALGIA; ARTICLE; BEHAVIOR DISORDER; CHILD; CHILL; DRUG RESPONSE; ENZYME ACTIVITY; FEVER; GENOTYPE; GRANULOCYTOPENIA; HAIR LOSS; HEADACHE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LEUKOPENIA; LIVER FIBROSIS; MALAISE; MOOD DISORDER; MYALGIA; NAUSEA; PRIORITY JOURNAL; SOMNOLENCE; VIRUS LOAD;

EID: 23944513998     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2005.05.004     Document Type: Article

References (9)

1. M.P. Manns J.G. McHutchison S.C. Gordon et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial Lancet 358 2001 958-965
2. T. Poynard M.F. Yuen V. Ratziu C.L. Lai Viral hepatits C Lancet 20 362 (9401) 2003 2095-2100
3. G.L. Davis J.B. Wong J.G. McHutchison M.P. Manns J. Harvey J. Albrecht Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C Hepatology 38 3 2003 645-652
4. P. Ferenci Predicting the therapeutic response in patients with chronic hepatitis C: The role of viral kinetic studies J Antimicrob Chemother 53 2004 15-18
5. S. Zeuzem E.J. Heathcote M.L. Shiffman et al. Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alfa for chronic hepatitis C J Hepatol 39 1 2003 106-111
6. P. Trimoulet V. de Ledinghen J. Foucher L. Castera H. Fleury P. Couzigou Predictive value of early HCV RNA quantitation for sustained response in nonresponders receiving daily interferon and ribavirin therapy J Med Virol 72 January (1) 2004 46-51
7. K. Mochizuki T. Kagawa S. Takashimizu et al. Effect of in vitro interferon-beta administration on hepatitis C virus in peripheral blood mononuclear cells as a predictive marker of clinical response to interferon treatment for chronic hepatitis C World J Gastroenterol 10 March (5) 2004 733-736
8. T. Poynard J. McHutchison M. Manns R.P. Myers J. Albrecht Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin Hepatology 38 August (2) 2003 481-492
9. D.E. Baker Pegylated interferon plus ribavirin for the treatment of chronic hepatitis C Rev Gastroenterol Disord Spring 3 2 2003 93-109